SPRINGVEST OYJ |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.92 EUR | 0.00% |
|
+2.50% | +16.59% |
| Apr. 26 | Agronomics investee raises additional EUR8 million | AN |
| Apr. 26 | Agronomics' Portfolio Company Raises Additional EUR8 Million for New Protein Product | MT |
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 54.67 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +16.59% | 29.52M | - | ||
| +3.75% | 36.06B | B | ||
| 0.00% | 18.31B | - | - | |
| +3.03% | 5.36B | - | C | |
| +0.62% | 3.14B | - | B- | |
| +10.79% | 2.87B | D+ | ||
| +18.81% | 2.82B | C- | ||
| -17.26% | 2.29B | C+ | ||
| +4.02% | 1.24B | - | - | |
| +5.32% | 1.16B | B |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SPRING Stock
- Ratings Springvest Oyj